Purpose
Breast cancer is the most common malignancy among women across the globe. Despite concerted efforts to improve the prevailing treatment modalities, the overall prognosis of
breast cancer remains unsatisfactory. Recently, antiproliferative activity of
Brevilin A (Brv-A), a